Jane Street Group LLC trimmed its position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 53.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 20,513 shares of the company's stock after selling 23,334 shares during the period. Jane Street Group LLC owned about 0.05% of Phibro Animal Health worth $431,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Sterling Capital Management LLC lifted its position in shares of Phibro Animal Health by 2.4% in the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock valued at $394,000 after acquiring an additional 448 shares in the last quarter. Rhumbline Advisers increased its position in shares of Phibro Animal Health by 0.6% during the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock worth $1,608,000 after purchasing an additional 484 shares in the last quarter. Los Angeles Capital Management LLC increased its position in shares of Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock worth $505,000 after purchasing an additional 503 shares in the last quarter. New York State Teachers Retirement System lifted its holdings in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares in the last quarter. Finally, SG Americas Securities LLC lifted its holdings in Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock valued at $276,000 after purchasing an additional 906 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.
Phibro Animal Health Trading Down 1.4%
Shares of PAHC stock traded down $0.35 on Wednesday, hitting $23.97. 149,710 shares of the stock traded hands, compared to its average volume of 203,016. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55. The firm's 50-day moving average price is $20.64 and its two-hundred day moving average price is $21.87. The stock has a market capitalization of $971.60 million, a PE ratio of 49.94, a PEG ratio of 0.45 and a beta of 0.62.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be given a $0.12 dividend. The ex-dividend date is Wednesday, June 4th. This represents a $0.48 annualized dividend and a yield of 2.00%. Phibro Animal Health's payout ratio is 61.54%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on PAHC shares. Barclays upped their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. Morgan Stanley upped their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research note on Thursday, May 8th. Finally, Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $20.00.
Get Our Latest Report on PAHC
Phibro Animal Health Company Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
